Research Article

[Retracted] A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis

Table 2

Summary of pooled ORs and 95%CI for TNF-α-308G/A gene polymorphism and subgroup analyses.

(GA vs. GG)(AA vs. GG)(GA + AA vs. GG)(AA vs. GA + GG)
OR, 95% CI P, I2OR, 95% CI P, I2OR, 95% CI P, I2OR, 95% CI P, I2

Total0.95 (0.70,1.30); I2 = 73%1.11 (0.66,1.85); I2 = 59%1.00 (0.73,1.37); I2 = 78%1.07 (0.70,1.63)P = 0.002; I2 = 54%
European0.86 (0.58,1.27)P = 0.002; I2 = 65%1.19 (0.42,3.37)P = 0.001; I2 = 67%0.93 (0.60,1.43); I2 = 74%0.43 (0.41,4.99)P = 0.0002; I2 = 73%
American0.95 (0.57,1.59)P = 0.11; I2 = 54%0.70 (0.28,1.77)P = 0.25; I2 = 29%0.91 (0.53,1.57)P = 0.09; I2 = 59%0.84 (0.63, 1.12)P = 0.75; I2 = 0%
African2.97 (0.56,15.64)P = 0.002; I2 = 83%2.08 (0.39,11.23)P = 0.03; I2 = 71%1.92 (0.67, 5.53)P = 0.003; I2 = 82%1.68 (0.44, 6.36)P = 0.09; I2 = 58%
Asian0.95 (0.38,2.35)P = 0.0001; I2 = 82%0.60 (0.28,1.30)P = 0.2; I2 = 37%0.97 (0.43,2.19)P = 0.0001; I2 = 83%0.75 (0.48, 1.18)P = 0.37; I2 = 0%
PBC0.90 (0.63,1.28)P = 0.002; I2 = 65%0.80 (0.22,2.88)P = 0.0001; I2 = 82%0.90 (0.59, 1.35)P = 0.0001; I2 = 76%0.98 (0.45, 2.10)P = 0.0008; I2 = 70%
HCV1.85 (0.58,5.88)P = 0.04; I2 = 82%3.02 (1.15,7.88)P = 0.5; I2 = 0%1.96 (0.71, 5.40)P = 0.004; I2 = 82%2.68 (1.04, 6.95)P = 0.63; I2 = 0%
ALC0.82 (0.23,2.92)P = 0.03; I2 = 79%2.08 (0.34,12.73)P = 0.27; I2 = 19%0.95 (0.39, 2.31)P = 0.10; I2 = 62%2.36 (0.24, 23.38)P = 0.16; I2 = 50%
HBV0.78 (0.32,1.92)P = 0.002; I2 = 76%0.64 (0.41,0.99)P = 0.36; I2 = 7%0.98 (0.45, 2.15)P = 0.0001; I2 = 83%0.74 (0.50, 1.10)P = 0.57; I2 = 0%